DO CUMEN T CO DE
AT I- PN- PH ARM - 2026
PROCTORE D P N P H A RM A C O L O G Y E X A M I N ATI O N
ATI PN
Pharmacology
Proctored Exam
Updated Edition
A comprehensive 60-question proctored examination aligned with
current ATI Practical Nursing Pharmacology curriculum standards
and the 2026-2027 NCLEX-PN test plan. Covers pharmacokinetics,
cardiovascular, respiratory, endocrine, neurological, anti-infective,
pain management, and dosage calculation domains with verified
rationales and ATI testing strategies.
Q UEST I O N S SECT I O N S CO GN I T I VE F O R M AT
60 8 R / A / An MCQ A-D
E X A M I N ATI O N C Y C L E
P R E PA R E D F O R
Practical Nursing Candidates 2026 - 2027
ATI P N P HA RM A C O L O GY P RO C TO RE D V O L UM E I · UP D ATE D E D I TI O N
,ATI PN Pharmacology Proctored Exam | Updated Edition 60 Questions & Answers
Examination Overview
Purpose: This proctored examination is designed to evaluate the practical nursing student's mastery of
pharmacological principles, medication safety, and clinical reasoning across the eight content domains aligned
with the ATI Practical Nursing (PN) Pharmacology test plan and the 2026-2027 NCLEX-PN blueprint. The exam
reflects current evidence-based medication administration standards, including updated high-alert medication
protocols, lifespan considerations, and the latest ATI pharmacology content revisions.
Structure: The examination consists of 60 multiple-choice questions distributed across eight sections covering
pharmacological principles, cardiovascular/hematologic, respiratory/GI, endocrine, neurological/psychotropic,
anti-infective, pain management, and medication calculation domains. Approximately 75% of items are
scenario-based requiring application or analysis, while 25% assess direct recall and dosage computation. Cognitive
distribution is 30% recall, 50% application, and 20% analysis.
Instructions: Select the single best answer for each question. Rationales provided after each item identify the
correct option, explain the underlying pharmacological reasoning, and address why each distractor is incorrect —
including medication classification, mechanism of action, adverse effects, nursing considerations, and safety
principles aligned with ATI testing strategies.
Time Limit Questions Format Passing Standard
Proctored 60 MCQ 4-option single-best-answer ATI PN Proficiency Level
Section 1 · Pharmacological Principles and Safe Medication Administration
Pharmacokinetics, Pharmacodynamics, Six Rights, & High-Alert Medications · Q1 - Q8
Q1. A practical nurse is preparing to administer 09:00 medications to a patient with hypertension. After
verifying the medication against the MAR, the nurse enters the patient's room, checks the wristband,
and asks the patient to state their name and date of birth. Which of the following actions best
represents the second of the "three checks" in medication administration?
A. Comparing the medication label to the MAR at the time of removal from the medication dispensing
system
B. Comparing the medication label to the MAR immediately before pouring or preparing the medication at
the patient's bedside
C. Comparing the medication label to the MAR one final time before discarding the packaging after
administration [CORRECT]
D. Asking the patient to verbally confirm the name and indication of each medication prior to swallowing
Correct Answer: C
Rationale
The three checks require the nurse to compare the medication label with the MAR three times: (1) when removing
the medication from storage, (2) immediately before preparing or pouring the dose, and (3) before discarding the
packaging or returning the medication to storage. Option B describes the second check performed at the bedside
before administration. Option A describes the first check, Option C describes the third check, and Option D, while
promoting patient engagement, is not part of the formal three-checks process defined by ATI safety protocols.
ATI PN Pharmacology Proctored Actual Exam | Page 1
, ATI PN Pharmacology Proctored Exam | Updated Edition 60 Questions & Answers
Q2. A patient receiving an oral medication asks why the drug requires multiple daily doses while another
drug taken for the same condition only needs once-daily dosing. The nurse explains that the half-life
of a medication is primarily determined by which pharmacokinetic process in most adult patients?
A. Absorption across the gastric mucosa
B. Distribution into adipose tissue
C. Hepatic metabolism via cytochrome P450 enzymes [CORRECT]
D. Renal tubular reabsorption
Correct Answer: C
Rationale
Although all four pharmacokinetic phases influence drug action, the half-life of most medications is primarily
determined by hepatic metabolism (biotransformation via the cytochrome P450 enzyme system) and renal excretion
of the parent drug and metabolites. In adult patients with intact hepatic function, hepatic clearance is the dominant
determinant of half-life for the majority of medications. Absorption determines onset, distribution determines
volume of distribution, and tubular reabsorption affects excretion rate but is not the primary determinant of half-life
for most agents. ATI PN content emphasizes metabolism and excretion as the elimination phases that govern dosing
intervals.
Q3. A patient is prescribed a medication with a narrow therapeutic index. The nurse identifies which of
the following implications as the most important safety consideration when caring for this patient?
A. The medication can be administered safely without regard to laboratory monitoring
B. Serum drug levels must be monitored routinely, and small dosing changes can produce toxicity or
therapeutic failure [CORRECT]
C. The medication has a wide margin of safety between the minimum effective and toxic concentrations
D. The medication does not interact with other drugs and is safe in patients with renal impairment
Correct Answer: B
Rationale
A narrow therapeutic index (TI) means the ratio between the minimum effective concentration and the minimum
toxic concentration is small; therefore, small dosing changes or drug interactions can precipitate either
subtherapeutic levels or toxicity. Examples include digoxin, lithium, warfarin, and phenytoin, all of which require
routine serum drug-level monitoring. Option A is incorrect because monitoring is essential; Option C describes a
wide therapeutic index (the opposite of the clinical scenario); and Option D is false because narrow-TI drugs
frequently have significant drug interactions and require dose adjustment in organ impairment.
Q4. A charge nurse is reviewing the unit's high-alert medication list with a newly licensed practical
nurse. Which statement by the LPN indicates that further teaching is required regarding high-alert
medications?
A. Insulin, heparin, and opioids are classified as high-alert medications because they carry a significant risk
of patient harm when used in error.
B. Independent double verification by two licensed nurses is required before administering high-alert IV
medications such as heparin infusions.
C. High-alert medications cause errors more frequently than other medications and therefore
require less stringent verification procedures. [CORRECT]
D. Look-alike/sound-alike (LASA) medications, such as hydroxyzine and hydralazine, require special
labeling and storage to prevent mix-ups.
ATI PN Pharmacology Proctored Actual Exam | Page 2
AT I- PN- PH ARM - 2026
PROCTORE D P N P H A RM A C O L O G Y E X A M I N ATI O N
ATI PN
Pharmacology
Proctored Exam
Updated Edition
A comprehensive 60-question proctored examination aligned with
current ATI Practical Nursing Pharmacology curriculum standards
and the 2026-2027 NCLEX-PN test plan. Covers pharmacokinetics,
cardiovascular, respiratory, endocrine, neurological, anti-infective,
pain management, and dosage calculation domains with verified
rationales and ATI testing strategies.
Q UEST I O N S SECT I O N S CO GN I T I VE F O R M AT
60 8 R / A / An MCQ A-D
E X A M I N ATI O N C Y C L E
P R E PA R E D F O R
Practical Nursing Candidates 2026 - 2027
ATI P N P HA RM A C O L O GY P RO C TO RE D V O L UM E I · UP D ATE D E D I TI O N
,ATI PN Pharmacology Proctored Exam | Updated Edition 60 Questions & Answers
Examination Overview
Purpose: This proctored examination is designed to evaluate the practical nursing student's mastery of
pharmacological principles, medication safety, and clinical reasoning across the eight content domains aligned
with the ATI Practical Nursing (PN) Pharmacology test plan and the 2026-2027 NCLEX-PN blueprint. The exam
reflects current evidence-based medication administration standards, including updated high-alert medication
protocols, lifespan considerations, and the latest ATI pharmacology content revisions.
Structure: The examination consists of 60 multiple-choice questions distributed across eight sections covering
pharmacological principles, cardiovascular/hematologic, respiratory/GI, endocrine, neurological/psychotropic,
anti-infective, pain management, and medication calculation domains. Approximately 75% of items are
scenario-based requiring application or analysis, while 25% assess direct recall and dosage computation. Cognitive
distribution is 30% recall, 50% application, and 20% analysis.
Instructions: Select the single best answer for each question. Rationales provided after each item identify the
correct option, explain the underlying pharmacological reasoning, and address why each distractor is incorrect —
including medication classification, mechanism of action, adverse effects, nursing considerations, and safety
principles aligned with ATI testing strategies.
Time Limit Questions Format Passing Standard
Proctored 60 MCQ 4-option single-best-answer ATI PN Proficiency Level
Section 1 · Pharmacological Principles and Safe Medication Administration
Pharmacokinetics, Pharmacodynamics, Six Rights, & High-Alert Medications · Q1 - Q8
Q1. A practical nurse is preparing to administer 09:00 medications to a patient with hypertension. After
verifying the medication against the MAR, the nurse enters the patient's room, checks the wristband,
and asks the patient to state their name and date of birth. Which of the following actions best
represents the second of the "three checks" in medication administration?
A. Comparing the medication label to the MAR at the time of removal from the medication dispensing
system
B. Comparing the medication label to the MAR immediately before pouring or preparing the medication at
the patient's bedside
C. Comparing the medication label to the MAR one final time before discarding the packaging after
administration [CORRECT]
D. Asking the patient to verbally confirm the name and indication of each medication prior to swallowing
Correct Answer: C
Rationale
The three checks require the nurse to compare the medication label with the MAR three times: (1) when removing
the medication from storage, (2) immediately before preparing or pouring the dose, and (3) before discarding the
packaging or returning the medication to storage. Option B describes the second check performed at the bedside
before administration. Option A describes the first check, Option C describes the third check, and Option D, while
promoting patient engagement, is not part of the formal three-checks process defined by ATI safety protocols.
ATI PN Pharmacology Proctored Actual Exam | Page 1
, ATI PN Pharmacology Proctored Exam | Updated Edition 60 Questions & Answers
Q2. A patient receiving an oral medication asks why the drug requires multiple daily doses while another
drug taken for the same condition only needs once-daily dosing. The nurse explains that the half-life
of a medication is primarily determined by which pharmacokinetic process in most adult patients?
A. Absorption across the gastric mucosa
B. Distribution into adipose tissue
C. Hepatic metabolism via cytochrome P450 enzymes [CORRECT]
D. Renal tubular reabsorption
Correct Answer: C
Rationale
Although all four pharmacokinetic phases influence drug action, the half-life of most medications is primarily
determined by hepatic metabolism (biotransformation via the cytochrome P450 enzyme system) and renal excretion
of the parent drug and metabolites. In adult patients with intact hepatic function, hepatic clearance is the dominant
determinant of half-life for the majority of medications. Absorption determines onset, distribution determines
volume of distribution, and tubular reabsorption affects excretion rate but is not the primary determinant of half-life
for most agents. ATI PN content emphasizes metabolism and excretion as the elimination phases that govern dosing
intervals.
Q3. A patient is prescribed a medication with a narrow therapeutic index. The nurse identifies which of
the following implications as the most important safety consideration when caring for this patient?
A. The medication can be administered safely without regard to laboratory monitoring
B. Serum drug levels must be monitored routinely, and small dosing changes can produce toxicity or
therapeutic failure [CORRECT]
C. The medication has a wide margin of safety between the minimum effective and toxic concentrations
D. The medication does not interact with other drugs and is safe in patients with renal impairment
Correct Answer: B
Rationale
A narrow therapeutic index (TI) means the ratio between the minimum effective concentration and the minimum
toxic concentration is small; therefore, small dosing changes or drug interactions can precipitate either
subtherapeutic levels or toxicity. Examples include digoxin, lithium, warfarin, and phenytoin, all of which require
routine serum drug-level monitoring. Option A is incorrect because monitoring is essential; Option C describes a
wide therapeutic index (the opposite of the clinical scenario); and Option D is false because narrow-TI drugs
frequently have significant drug interactions and require dose adjustment in organ impairment.
Q4. A charge nurse is reviewing the unit's high-alert medication list with a newly licensed practical
nurse. Which statement by the LPN indicates that further teaching is required regarding high-alert
medications?
A. Insulin, heparin, and opioids are classified as high-alert medications because they carry a significant risk
of patient harm when used in error.
B. Independent double verification by two licensed nurses is required before administering high-alert IV
medications such as heparin infusions.
C. High-alert medications cause errors more frequently than other medications and therefore
require less stringent verification procedures. [CORRECT]
D. Look-alike/sound-alike (LASA) medications, such as hydroxyzine and hydralazine, require special
labeling and storage to prevent mix-ups.
ATI PN Pharmacology Proctored Actual Exam | Page 2
